Effect of rilmakalim on detrusor contraction in the presence and absence of urothelium.
Openers of K(ATP) channels are known to inhibit KCl-, carbachol- and also electrically induced contractions in detrusor muscle strips from various species. Contractions of isolated strips of urinary bladder are usually of higher amplitude when the urothelium has been removed. This has been explained by the release of an urothelium-derived relaxing factor. In this study we examined whether intact urothelium may modulate the effect of the selective KATP channel opener rilmakalim. Contractile responses to 85 mM KCl and 10 microM carbachol were measured in detrusor strips from mouse, pig and man. In the presence of an intact urothelium, contractions were significantly reduced in strips from all three species investigated. In preparations with urothelium rilmakalim reduced KCl contractions with similar potency and efficacy [-logIC50 (M) 4.6 to 5.1; Effmax reduction to 14-30% of control]. However, in urothelium-denuded strips rilmakalim was more potent in pig (-logIC50 5.5) than in mouse and man (-logIC50 4.7 and 4.4, respectively). The order of potency for rilmakalim to suppress carbachol-induced contractions was pig (-logIC50 6.7)>man (5.8)>mouse (4.7); contractions were significantly more reduced in pig (Effmax reduction to 11+/-2%, n=10) and in mouse (21+/-2%, n=8) than in human detrusor (55+/-5%, n=5). The presence of urothelium did not affect the concentration-response curves for rilmakalim, with the exception of KCl-induced contractions in pig. Only the rilmakalim-induced relaxation of carbachol-mediated contractions in pig were prevented by the KATP channel blocker glibenclamide. We conclude that with this one exception, the responses to rilmakalim in detrusor contractions were not mediated by KATP channel opening.
Wuest
Melinda
M
Institut für Pharmakologie und Toxikologie, Medizinische Fakultät, TU Dresden, Fetscherstrasse 74, 01307, Dresden, Germany. melinda.wuest@mailbox.tu-dresden.de
Kaden
Susann
S
Hakenberg
Oliver W
OW
Wirth
Manfred P
MP
Ravens
Ursula
U
D000818:Animals; D002217:Carbachol / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D002839:Chromans / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D008916:Miotics / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects*; D009125:Muscle Relaxants, Central / Q000494:pharmacology*; D009130:Muscle, Smooth / Q000187:drug effects; D015221:Potassium Channels / Q000187:drug effects; D011189:Potassium Chloride / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D013045:Species Specificity; D013552:Swine; D019459:Urothelium / Q000187:drug effects / Q000502:physiology*
D002839:Chromans; D008916:Miotics; D009125:Muscle Relaxants, Central; D015221:Potassium Channels; D011759:Pyrrolidines; C075012:rilmakalim; D011189:Potassium Chloride; D002217:Carbachol